Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|February 23, 2005
Cytogenetic testing for therapeutic indication in cancerSuneel Mundle, Yelina Noskina
Annals of Hematology|March 21, 2008
Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysisVictor Moyo, Patrick Lefebvre, Mei Sheng Duh, et al.
Cancer|January 20, 2009
An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approachSuneel Mundle, Patrick Lefebvre, Francis Vekeman, et al.
Frontiers in Oncology|September 14, 2020
Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid TumorsSimon Chowdhury, Paul Mainwaring, Liangcai Zhang, et al.
Prostate Cancer and Prostatic Diseases|December 20, 2024
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS)Benjamin L Maughan, Yanfang Liu, Suneel Mundle, et al.
Scientific Reports|April 19, 2025
The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan)Masaki Shiota, Yanfang Liu, Suneel Mundle, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2021
Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE studyGiulia Baciarello, Mustafa Özgüroğlu, Suneel Mundle, et al.
Japanese Journal of Clinical Oncology|March 20, 2020
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 studyHiroyoshi Suzuki, Toshitaka Shin, Satoshi Fukasawa, et al.
British Journal of Haematology|March 12, 2002
Excessive apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical confronting cisternae in bone marrow biopsies of myelodysplastic syndrome patientsVilasini Shetty, Seema Hussaini, Sairah Alvi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 9, 2024
Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysisDing-Wei Ye, Hirotsugu Uemura, Byung Ha Chung, et al.
Pageof 2